Quick Answer
Eton Pharmaceuticals, Inc. reported Total Assets of $92.11 million for fiscal year 2025.
Eton Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $92.11M | +21.0% |
| 2024 | $76.12M | +139.8% |
| 2023 | $31.74M | +26.8% |
| 2022 | $25.03M | -8.9% |
| 2021 | $27.46M | +4.4% |
| 2020 | $26.32M | +54.2% |
| 2019 | $17.07M | -39.7% |
| 2018 | $28.33M | +110.7% |
| 2017 | $13.44M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $104.51M | +191.6% | +2.8% |
| June 30, 2025 | $101.68M | +219.5% | +21.0% |
| March 31, 2025 | $84.03M | +172.9% | +10.4% |
| December 31, 2024 | $76.12M | +139.8% | +112.4% |
| September 30, 2024 | $35.84M | +13.7% | +12.6% |
| June 30, 2024 | $31.82M | +2.9% | +3.3% |
| March 31, 2024 | $30.79M | +28.7% | -3.0% |
| December 31, 2023 | $31.74M | +26.8% | +0.7% |
- Eton Pharmaceuticals, Inc. showed an increase of +21.0% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Eton Pharmaceuticals, Inc.’s total assets has grown by 585.2% (from $13.44 million to $92.11 million).
- The most recent figure is from Eton Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: